DAWN
NASDAQ · Biotechnology
Day One Biopharmaceuticals I
$21.53
+0.00 (+0.00%)
Open$21.53
Previous Close$21.53
Day High$21.53
Day Low$21.53
52W High$21.53
52W Low$7.11
Volume—
Avg Volume1.34M
Market Cap2.22B
P/E Ratio—
EPS$-1.04
SectorBiotechnology
Analyst Ratings
Hold
13 analysts
Price Target
+161.4% upside
Current
$21.53
$21.53
Target
$56.28
$56.28
$41.40
$56.28 avg
$65.73
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 158.38M | 322.81M | 330.87M |
| Net Income | -107,457,204 | -68,873,512 | -86,473,457 |
| Profit Margin | -67.9% | -21.3% | -26.1% |
| EBITDA | -127,545,367 | -92,549,420 | -89,278,899 |
| Free Cash Flow | — | -81,242,335 | -91,466,852 |
| Rev Growth | — | +3.3% | -3.7% |
| Debt/Equity | — | 0.57 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |